Dr. Abdulhameed Albarraq Alhazmi is a Consultant Endocrinologist and Internal Medicine Specialist at Jazan University Hospital, Saudi Arabia, with a focused interest in obesity medicine and telemedicine in endocrine care.
Abdulhameed completed his Endocrinology and Metabolism Fellowship at King Abdulaziz Medical City (NGHA) in Riyadh, and is board-certified in Internal Medicine from King Faisal Specialist Hospital in Jeddah. He is currently completing an Obesity Medicine Fellowship at St. Vincent’s University Hospital / University College Dublin, Ireland.
Abdulhameed’s work centres on improving patient outcomes through innovative clinical models. He has led telemedicine initiatives, contributed to national healthcare projects, and presented at international meetings, including the American Thyroid Association Annual Meeting. Abdulhameed is also involved in academic teaching at Jazan University and is active in research on obesity, metabolic disorders, and digital endocrine care.
Alongside his clinical work, Abdulhameed has published a short story collection in Arabic and received awards for both medical excellence and creative writing.
Introduction The therapeutic approach to obesity and type 2 diabetes mellitus (T2DM) is evolving in a similar way to how clinicians use antibiotics: targeting several pathways that often produce stronger and more durable effects than acting on a single pathway. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) laid the foundation, but the complexity of fat mass… Read more »
Sign up for monthly updates featuring our latest expert insights, upcoming webinars, and much more.
Subscribe